Aclaris Therapeutics, Inc.
ACRSDrugs in Pipeline
20
Phase 3 Programs
3
Upcoming Catalysts
2
Next Catalyst
Aug 6, 2026
7wMarket Overview
Stock performance and key metrics
2 upcoming, 0 past
A-101
Common Wart
Active
Common Wart
A-101 Solution
Seborrheic Keratosis
ATI-502
Atopic Dermatitis
ATI-045
Atopic Dermatitis
ATI-1777
Atopic Dermatitis
A-101 Vehicle
Seborrheic Keratosis
A-101 Topical Solution 40%
Dermatosis Papulosa Nigra
ATI-450 50 mg oral tablet BID
Rheumatoid Arthritis
A-101 Topical Solution
Common Wart
ATI-501 400mg BID (Low dose)
Alopecia
ATI-50002 topical solution
Vitiligo
A-101 25%
Seborrheic Keratosis (SK)
ATI-2138
Atopic Dermatitis
ATI-50002
Androgenetic Alopecia
A-101 Vehicle Solution
Common Wart
Vehicle
Alopecia Universalis (AU)
A-101 Solution 40
Common Warts
ATI-1777 2.0% w/w
Atopic Dermatitis
ATI-450
Rheumatoid Arthritis
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
A-101 | Phase 3 | Common Wart | - | - |
Active | Phase 3 | Common Wart | - | |
A-101 Solution | Phase 3 | Seborrheic Keratosis | - | - |
ATI-502 | Phase 2 | Atopic Dermatitis | - | - |
ATI-045 | Phase 2 | Atopic Dermatitis | - | - |
ATI-1777 | Phase 2 | Atopic Dermatitis | - | - |
A-101 Vehicle | Phase 2 | Seborrheic Keratosis | - | - |
A-101 Topical Solution 40% | Phase 2 | Dermatosis Papulosa Nigra | - | - |
ATI-450 50 mg oral tablet BID | Phase 2 | Rheumatoid Arthritis | - | - |
A-101 Topical Solution | Phase 2 | Common Wart | - | - |
ATI-501 400mg BID (Low dose) | Phase 2 | Alopecia | - | - |
ATI-50002 topical solution | Phase 2 | Vitiligo | - | - |
A-101 25% | Phase 2 | Seborrheic Keratosis (SK) | - | - |
ATI-2138 | Phase 2 | Atopic Dermatitis | - | - |
ATI-50002 | Phase 2 | Androgenetic Alopecia | - | - |
A-101 Vehicle Solution | Phase 2 | Common Wart | - | - |
Vehicle | Phase 2 | Alopecia Universalis (AU) | - | - |
A-101 Solution 40 | Phase 2 | Common Warts | - | - |
ATI-1777 2.0% w/w | Phase 2 | Atopic Dermatitis | - | - |
ATI-450 | Phase 2 | Rheumatoid Arthritis | - | - |
Atopic Dermatitis
5 drugs in this indication
Common Wart
4 drugs in this indication
Rheumatoid Arthritis
2 drugs in this indication
Seborrheic Keratosis
2 drugs in this indication
Alopecia Universalis (AU)
1 drug in this indication
Dermatosis Papulosa Nigra
1 drug in this indication
Alopecia
1 drug in this indication
Vitiligo
1 drug in this indication
Seborrheic Keratosis (SK)
1 drug in this indication
Androgenetic Alopecia
1 drug in this indication
Common Warts
1 drug in this indication
Hidradenitis Suppurativa
1 drug in this indication
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)